Duo Xu
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 16, 2026
Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.Duo Xu, Yanyun Gao, Shengchen Liu
|Jul 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.Duo Xu, Yanyun Gao, Shengchen Liu
|Dec 06, 2024
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer.Liang Zhao, Haibin Deng, Jingyi Zhang
|Jun 15, 2024
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.Duo Xu, Shiyuan Yin, Yongqian Shu
Pageof 1
Frequent Collaborators
3 joint publications
Haibin Deng
3 joint publications
Ralph A Schmid
3 joint publications
Ren-Wang Peng
2 joint publications
Yongqian Shu
2 joint publications
Shun-Qing Liang
1 joint publications
Yongqian Shu
1 joint publications
Liang Zhao
1 joint publications
Nicola Zamboni
1 joint publications
Haitang Yang
1 joint publications
Haiqing Zhong